Article info

PDF

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
  1. Correspondence to:
    Norihiro Nishimoto
    MD, Laboratory of Immune Regulation, Graduate School of Frontier Biosciences, Osaka University 1–3, Yamada-oka, Suita, Osaka, 565-0871, Japan; norihiro{at}fbs.osaka-u.ac.jp
View Full Text

Citation

Nishimoto N, Hashimoto J, Miyasaka N, et al
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

Publication history

  • Accepted April 14, 2007
  • First published May 7, 2007.
Online issue publication 
August 10, 2007

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.